23840712|t|Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3beta acetylation.
23840712|a|Resolvin D1 (RvD1) is a lipid-derived mediator generated during the resolution inflammation. While the immunoresolvent effects of Resolvins have been extensively studied in leukocytes, actions of Resolvins on intrinsic kidney cells have received little attention. The podocyte plays a central role in glomerular function, and podocyte damage can lead to proteinuria and glomerulosclerosis. This study examined whether RvD1 has renoprotective effects upon podocytes. We investigated a mouse model of adriamycin (ADR) nephropathy featuring rapid induction of podocyte damage and proteinuria followed by glomerulosclerosis. We identified a progressive loss of synaptopodin expression over a 28 day time-course of ADR nephropathy which was associated with increased acetylation of 14-3-3beta and reduced synaptopodin phosphorylation. Groups of mice were given once daily RvD1 treatment (4 ng/g body weight/day) starting either 30 min (early treatment) or 14 days (late treatment) after ADR injection and continued until mice were killed on day 28. Early, but not late, RvD1 treatment attenuated ADR-induced proteinuria, glomerulosclerosis and tubulointerstitial fibrosis, modified macrophages from an M1 to M2 phenotype. Early RvD1 treatment prevented the down-regulation of synaptopodin expression and changes in 14-3-3beta acetylation and synaptopodin phosphorylation. In a podocyte cell line, RvD1 was shown to prevent rapid TNF-alpha-induced down-regulation of synaptopodin expression. In transfection studies, TNF-alpha-induced a decrease in synaptopodin phosphorylation and an increase in acetylation of 14-3-3beta, resulting in disassociation between 14-3-3beta and synaptopodin. RvD1 prevented TNF-alpha induced post-translational modification of synaptopodin and 14-3-3beta proteins, and maintained the synaptopodin/14-3-3beta interaction. Furthermore, replacement of lysine K51, or K117+K122 in 14-3-3beta with glutamine, to mimic lysine acetylation, significantly reduced the interaction between 14-3-3beta and synaptopodin. In conclusion, our studies provide the first evidence that RvD1 can protect against podocyte damage by preventing down-regulation of synaptopodin through inhibition of 14-3-3beta/synaptopodin dissociation. RvD1 treatment may have potential application in the treatment of chronic kidney disease. 
23840712	0	11	Resolvin D1	Chemical	MESH:C518399
23840712	34	44	adriamycin	Chemical	MESH:D004317
23840712	53	64	nephropathy	Disease	MESH:D007674
23840712	87	97	14-3-3beta	Gene	54401
23840712	111	122	Resolvin D1	Chemical	MESH:C518399
23840712	124	128	RvD1	Chemical	MESH:C518399
23840712	135	140	lipid	Chemical	MESH:D008055
23840712	190	202	inflammation	Disease	MESH:D007249
23840712	241	250	Resolvins	Chemical	-
23840712	307	316	Resolvins	Chemical	-
23840712	465	476	proteinuria	Disease	MESH:D011507
23840712	481	499	glomerulosclerosis	Disease	MESH:D005921
23840712	529	533	RvD1	Chemical	MESH:C518399
23840712	595	600	mouse	Species	10090
23840712	610	620	adriamycin	Chemical	MESH:D004317
23840712	627	638	nephropathy	Disease	MESH:D007674
23840712	688	699	proteinuria	Disease	MESH:D011507
23840712	712	730	glomerulosclerosis	Disease	MESH:D005921
23840712	768	780	synaptopodin	Gene	104027
23840712	825	836	nephropathy	Disease	MESH:D007674
23840712	888	898	14-3-3beta	Gene	54401
23840712	911	923	synaptopodin	Gene	104027
23840712	951	955	mice	Species	10090
23840712	978	982	RvD1	Chemical	MESH:C518399
23840712	1127	1131	mice	Species	10090
23840712	1176	1180	RvD1	Chemical	MESH:C518399
23840712	1214	1225	proteinuria	Disease	MESH:D011507
23840712	1227	1245	glomerulosclerosis	Disease	MESH:D005921
23840712	1250	1277	tubulointerstitial fibrosis	Disease	MESH:D005355
23840712	1334	1338	RvD1	Chemical	MESH:C518399
23840712	1382	1394	synaptopodin	Gene	104027
23840712	1421	1431	14-3-3beta	Gene	54401
23840712	1448	1460	synaptopodin	Gene	104027
23840712	1503	1507	RvD1	Chemical	MESH:C518399
23840712	1535	1544	TNF-alpha	Gene	21926
23840712	1572	1584	synaptopodin	Gene	104027
23840712	1622	1631	TNF-alpha	Gene	21926
23840712	1654	1666	synaptopodin	Gene	104027
23840712	1717	1727	14-3-3beta	Gene	54401
23840712	1765	1775	14-3-3beta	Gene	54401
23840712	1780	1792	synaptopodin	Gene	104027
23840712	1794	1798	RvD1	Chemical	MESH:C518399
23840712	1809	1818	TNF-alpha	Gene	21926
23840712	1862	1874	synaptopodin	Gene	104027
23840712	1879	1889	14-3-3beta	Gene	54401
23840712	1919	1931	synaptopodin	Gene	104027
23840712	1932	1942	14-3-3beta	Gene	54401
23840712	2012	2022	14-3-3beta	Gene	54401
23840712	2114	2124	14-3-3beta	Gene	54401
23840712	2129	2141	synaptopodin	Gene	104027
23840712	2202	2206	RvD1	Chemical	MESH:C518399
23840712	2276	2288	synaptopodin	Gene	104027
23840712	2311	2321	14-3-3beta	Gene	54401
23840712	2322	2334	synaptopodin	Gene	104027
23840712	2349	2353	RvD1	Chemical	MESH:C518399
23840712	2415	2437	chronic kidney disease	Disease	MESH:D051436
23840712	Negative_Correlation	104027	21926
23840712	Negative_Correlation	MESH:D007674	104027
23840712	Negative_Correlation	MESH:C518399	MESH:D005355
23840712	Negative_Correlation	MESH:C518399	MESH:D005921
23840712	Positive_Correlation	MESH:D004317	MESH:D005921
23840712	Positive_Correlation	MESH:D004317	MESH:D007674
23840712	Association	104027	54401
23840712	Negative_Correlation	MESH:C518399	104027
23840712	Association	21926	54401
23840712	Negative_Correlation	MESH:C518399	21926
23840712	Positive_Correlation	MESH:D004317	MESH:D011507
23840712	Association	MESH:D004317	54401
23840712	Association	MESH:D007674	54401
23840712	Negative_Correlation	MESH:C518399	MESH:D011507
23840712	Positive_Correlation	MESH:C518399	54401
23840712	Association	MESH:C518399	MESH:D007674
23840712	Negative_Correlation	MESH:C518399	MESH:D007249

